(Q36492886)

14 August 2017

1 reference

title

Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder (English)

1 reference

attention deficit hyperactivity disorder

14 August 2017

1 reference

1 reference

1 reference

4

M Lynn Crismon

1 reference

14 August 2017

Aaron P Gibson

1

1 reference

14 August 2017

Tawny L Bettinger

series ordinal

2

1 reference

14 August 2017

Nick C Patel

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

30 May 2006

1 reference

Annals of Pharmacotherapy

14 August 2017

1 reference

14 August 2017

40

1 reference

14 August 2017

6

1 reference

14 August 2017

1134-1142

1 reference

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

14 August 2017

1 reference

Neurobiology of attention-deficit hyperactivity disorder.

21 January 2018

1 reference

Stimulant drug treatment of hyperactivity: biochemical correlates.

21 January 2018

1 reference

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

21 January 2018

1 reference

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

21 January 2018

1 reference

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

21 January 2018

1 reference

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

21 January 2018

1 reference

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

21 January 2018

1 reference

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

21 January 2018

1 reference

Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

Tourette's syndrome: are stimulants safe?

21 January 2018

1 reference

Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.

21 January 2018

1 reference

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

21 January 2018

1 reference

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

21 January 2018

1 reference

Depression of Growth in Hyperactive Children on Stimulant Drugs

21 January 2018

1 reference

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height

21 January 2018

1 reference

Serum and brain concentrations of methylphenidate: implications for use and abuse

21 January 2018

1 reference

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

The use, misuse and diversion of prescription stimulants among middle and high school students.

21 January 2018

1 reference

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G582

1 reference

14 August 2017

1 reference